0
0
Dr Faustine Engelbert Ndugulile has been nominated as the next Regional Director for the World Health Organization (WHO) African Region, taking the reins from Dr Matshidiso Moeti, who has served two five-year terms at the helm.
African Member States voted to nominate Dr Ndugulile during the Seventy-fourth session of the WHO Regional Committee for Africa, held in Brazzaville, Republic of the Congo. Other candidates were Dr Boureima Hama Sambo (proposed by Niger,) Dr Ibrahima Socé Fall (proposed by Senegal) and Dr Richard Mihigo (proposed by Rwanda).
Dr Ndugulile’s nomination will be submitted for appointment by the 156th session of the WHO Executive Board, which takes place in February 2025 in Geneva, Switzerland. The newly appointed Regional Director will take office thereafter for a five-year term and be eligible for reappointment once.
In his acceptance remarks, Dr Ndugulile expressed commitment to advancing health of the people of the region. “I’m truly honoured and humbled to be elected to the position of WHO Regional Director for Africa. I thank Member States for the trust shown in me. I promise to work with you and I believe that together we can build a healthier Africa,” said Dr Ndugulile.
Dr Tedros Adhanom Ghebreyesus, WHO Director-General, congratulated Dr Ndugulile on his election as Regional Director for Africa, and praised Dr Sambo, Dr Fall and Dr Mihigo on their campaigns.
“Dr Ndugulile has earned the confidence and trust of the Member States of the region to be elected the next Regional Director for WHO Africa. This is a great privilege, and a very great responsibility,” said Dr Tedros. “I and the entire WHO family in Africa and around the world will support you every step of the way.”
Dr Tedros also thanked Dr Moeti, the outgoing WHO Regional Director, for 10 years of commitment and excellence in service of the countries and people of Africa.
“I thank my sister Dr Moeti for everything she has done for the health of the people of Africa, but also for who she is,” said Dr Tedros. “I thank her for the example she has set, and the legacy she has left.”
Dr Moeti congratulated Dr Ndugulile and wished him success. “I would like to congratulate you for being elected as the Regional Director for Africa. This is an extremely fulfilling role. Despite the many challenges, I know you will take the baton and go on to accelerate the gains already made, putting the health and well-being of the people of Africa at the centre,” said Dr Moeti.
World Health Organization
About Author
OTHER ARTICLES
Zambia : The vital role of community health assistants in public health surveillance
Lusaka — African health ministers and partners are calling for increased investment in integrated health services to address the growing burden of severe noncommunicable diseases (NCDs), particularly those affecting women and underserved populations across the region. At a high-level side event during the Seventy-fifth session of the WHO Regional Committee for Africa, delegates emphasized the urgent need for equitable access to prevention, screening, treatment, and rehabilitation across the continuum of care for NCDs. Disparities are especially pronounced in rural areas, where health infrastructure and services remain inadequate. Breast and cervical cancers are among the leading causes of cancer-related deaths among women in sub-Saharan Africa—particularly cervical cancer, which is both preventable and treatable. It remains the most common cause of cancer death for women in the region. In 2022, Africa accounted for nearly a quarter (23%) of the 76 000 global cervical cancer deaths. Meanwhile, severe NCDs such as Type 1 diabetes, sickle cell disease, and heart conditions claim more than half a million lives annually, including among children, adolescents, and young adults in some of the continent’s poorest communities. Inequitable access to health services continues to hinder efforts to reduce this burden. To improve cervical and breast cancer care in the region, urgent investment is needed in leadership, governance, and financing. Strengthening these foundations is critical in the current funding landscape. Advancements in strategic planning, healthcare infrastructure, workforce training, and—most importantly—equitable access to screening, diagnostic, and treatment services are essential. To address these challenges, WHO and its partners showcased successful integrated models such as the Women’s Integrated Care for Cancer Services (WICS), the BEAT Breast Cancer Project, and the PEN-Plus Strategy. WICS strengthens early detection, treatment, and integration of women’s cancer services into primary health care systems in Côte d’Ivoire, Kenya, and Zimbabwe. The BEAT Breast Cancer Project is a transformative multi-year initiative aimed at reducing breast cancer mortality among women in Tanzania and Ghana through early detection, timely diagnosis, and comprehensive treatment access. “PEN-Plus, WICS and the BEAT Breast Cancer Initiative are models for a new standard of care, rooted in equity, access and health justice. I urge countries to prioritize policies that embed these models into broader health system strengthening, said Dr Mohamed Janabi, WHO Regional Director for Africa”. Côte d’Ivoire offers a compelling example of progress, combining high HPV vaccination coverage—reaching over three million girls (91.4%)—with WICS-supported community-based screening campaigns to strengthen cervical cancer prevention. In Kenya, cervical cancer screening has been successfully integrated into national health services. “This gathering marks a pivotal moment to accelerate action for breast cancer prevention in Africa. We deeply value the leadership of the Ministries of Health of Ghana and Tanzania, and the steadfast support of the Pfizer Foundation in helping us achieve this milestone. The side event builds momentum for the policy prioritization of women’s cancers, partnerships to strengthen the broader women’s cancer ecosystem, and advance a health-systems approach to breast cancer prevention and management”, said Dr Somesh Kumar, Senior Director, Jhpiego. PEN-Plus expands access to care for severe NCDs at the district hospital level. Since its implementation, 20 countries in Africa have increased access to services for severe NCDs. Over 15 000 people are currently receiving treatment for chronic conditions such as sickle cell disease and Type 1 diabetes through PEN-Plus clinics.
Confirmed Case of Mpox in Senegal: Situation Update (as of August 27, 2025)